Based on current research, the targets of ferroptosis in lung cancer mainly focus on the regulation of antioxidant pathways, among which GPX4 and SLC7A11 are the core targets of GSH-dependent antioxidant pathways (Xing et al., 2023). Here, GPX4 is linked to lung cancer.